德克萨斯州的新生儿体外膜肺氧合

Neonatal extracorporeal membrane oxygenation in Texas.

作者信息

Zwischenberger J B, Null D, Goldthorn J, Harper N

机构信息

Division of Cardiothoracic Surgery, UTMB, Galveston 77550.

出版信息

Tex Med. 1990 Aug;86(8):72-9.

PMID:2399508

Abstract

Extracorporeal membrane oxygenation (ECMO) has been a successful treatment (80% survival) in over 3,000 neonates with severe respiratory failure (80% predicted mortality without ECMO). ECMO is prolonged extracorporeal cardiopulmonary bypass achieved by extrathoracic vascular cannulation using a modified heart-lung machine. ECMO as treatment for severe respiratory failure in neonates is currently available in Texas in San Antonio, Galveston, Lubbock, and Dallas. Of 116 Texas neonates treated with ECMO, 74% survived. Because of the distances between ECMO programs in Texas, early communication with the nearest center is highly recommended.

摘要

体外膜肺氧合（ECMO）已成功应用于3000多名患有严重呼吸衰竭的新生儿（未经ECMO治疗预计死亡率为80%，而经ECMO治疗存活率达80%）。ECMO是通过使用改良心肺机经胸外血管插管实现的延长体外心肺转流。目前在得克萨斯州的圣安东尼奥、加尔维斯顿、拉伯克和达拉斯可利用ECMO治疗新生儿严重呼吸衰竭。在得克萨斯州接受ECMO治疗的116名新生儿中，74%存活。由于得克萨斯州各ECMO治疗中心之间距离较远，强烈建议尽早与最近的中心取得联系。